Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapyJuliane M. Jürgensmeier, Paulo M. Hoff, Laura Brooks et al.|British Journal of Cancer|2013Cited by 64